Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combo-PEP: Doxycycline Tissue Pharmacology for STI PEP
NCT04860505Phase 4Completed
- Sponsor
- Emory University
- Start
- May 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxycycline in sexually transmitted diseases (STD), sponsored by Emory University. Started May 2021; status: completed.
02
Drugs
doxycycline
03
Conditions
sexually transmitted diseases (STD)
Beyond the preview
Go deeper on NCT04860505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04860505.